Total Debt
$34.5M
Net Debt
-$22.1M
TriSalus Life Sciences, Inc. currently has $34.5M in total debt. Net debt is -$22.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TLSI • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.03 | 0.06 | -0.02Net Cash | 0.07 | 48.6% |
| 2025-12-31 | 0.03 | 0.02 | 0.01 | 0.04 | 97.5% |
| 2025-09-30 | 0.03 | 0.02 | 0.01 | 0.04 | 93.6% |
| 2025-06-30 | 0.03 | 0.03 | 0.01 | 0.04 | 81.5% |
| 2025-03-31 | 0.03 | 0.01 | 0.02 | 0.03 | 115.7% |
| 2024-12-31 | 0.02 | 0.01 | 0.02 | 0.02 | 98.6% |
| 2024-09-30 | 0.02 | 0.01 | 0.01 | 0.03 | 85.3% |
| 2024-06-30 | 0.02 | 0.02 | 0.01 | 0.03 | 70.2% |
| 2024-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.02 | 8.8% |
| 2023-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.02 | 6.5% |
| 2023-09-30 | 0.00 | 0.02 | -0.02Net Cash | 0.03 | 5.1% |
| 2023-06-30 | 0.00 | 0.00 | -0.00Net Cash | 0.02 | 10.7% |
| 2023-03-31 | 0.00 | 0.01 | -0.00Net Cash | 0.02 | 9.4% |
| 2022-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.02 | 8.9% |
| 2022-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.02 | 7.7% |
| 2022-06-30 | 0.00 | 0.00 | 0.00 | 0.25 | 0.6% |
| 2022-03-31 | 0.00 | 0.00 | 0.00 | 0.25 | 0.3% |
| 2021-12-31 | 0.00 | 0.03 | -0.03Net Cash | 0.04 | 0.0% |
| 2021-09-30 | 0.00 | 0.00 | -0.00Net Cash | 0.25 | 0.0% |
| 2021-06-30 | 0.00 | 0.00 | -0.00Net Cash | 0.25 | 0.0% |
| 2021-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.25 | 0.0% |
| 2020-12-31 | 0.04 | 0.00 | 0.04 | 0.01 | 519.0% |
| 2020-09-30 | 0.00 | 0.00 | 0.00 | 0.00 | 63.0% |